α1-receptor or adenosine A1-receptor dependent pathway alone is not sufficient but summation of these pathways is required to achieve an ischaemic preconditioning effect in rabbits

Clinical and Experimental Pharmacology and Physiology

Volumn 32, Issue 4, 2005, Pages 263-268

  Baba, Kaori ^a   Minatoguchi, Shinya ^a   Zhang, Chengxi ^a   Kariya, Tatsuya ^a   Uno, Yoshihiro ^a   Kawai, Takao ^a   Takahashi, Masahiko ^a   Takemura, Genzou ^a   Fujiwara, Hisayoshi ^a  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

1 receptor; Adenosine A1 receptor; Infarct size; Ischaemic preconditioning; Protein kinase C

Indexed keywords

8 (4 SULFOPHENYL)THEOPHYLLINE; ADENOSINE A1 RECEPTOR; ADENOSINE A1 RECEPTOR AGONIST; ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; BUNAZOSIN; PHENYLISOPROPYLADENOSINE; PLACEBO; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; STAUROSPORINE; TYRAMINE; 8-(4-SULFOPHENYL)THEOPHYLLINE; ADENOSINE; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; DRUG DERIVATIVE; ENZYME INHIBITOR; N (1 METHYL 2 PHENYLETHYL)ADENOSINE; N-(1-METHYL-2-PHENYLETHYL)ADENOSINE; QUINAZOLINE DERIVATIVE; THEOPHYLLINE; VASODILATOR AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; HEART INFARCTION PREVENTION; HEART INFARCTION SIZE; HEMODYNAMICS; MALE; NONHUMAN; RABBIT; REGULATORY MECHANISM; STATISTICAL ANALYSIS; ANIMAL; BLOOD PRESSURE; DRUG ANTAGONISM; DRUG POTENTIATION; HEART INFARCTION; HEART RATE; PATHOLOGY; PHYSIOLOGY;

ADENOSINE; ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; BLOOD PRESSURE; ENZYME INHIBITORS; HEART RATE; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; MYOCARDIAL INFARCTION; PROTEIN KINASE C; QUINAZOLINES; RABBITS; RECEPTOR, ADENOSINE A1; RECEPTORS, ADRENERGIC, ALPHA-1; STAUROSPORINE; THEOPHYLLINE; TYRAMINE; VASODILATOR AGENTS;

EID: 17844389306     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0305-1870.2005.04185.x     Document Type: Article

References (20)

1. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium. Circulation 1986; 74: 1124-36.
2. Li GC, Vasquez JA, Gallagher KP, Lucchesi BR. Myocardial protection with preconditioning. Circulation 1990; 82: 609-19.
3. Scott RJ, Rohmann S, Braun ER, Schaper W. Ischemic preconditioning reduces infarct size in swine myocardium. Circ. Res. 1990; 66: 1133-42.
4. Liu GS, Thornton J, Van Winkle DM, Stanley AWH, Olsson, RA, Downey JM. Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart. Circulation 1991; 84: 350-6.
5. Yellon DM, Alkhulaifi AM, Browne EE, Pugsley WB. Ischaemic preconditioning limits infarct size in the rat heart. Cardiovasc. Res. 1992; 26: 983-7.
6. 1- adrenergic agonist precondition rabbit ischemic myocardium independent of adenosine by direct activation of protein kinase C. Circ. Res. 1994; 75: 576-85.
7. 1a-adrenoceptors in rabbits. J. Cardiovasc. Pharmacol. 1997; 30: 437-45.
8. Ytrehus K, Liu Y, Downey J. Preconditioning protects ischemic rabbit heart by protein kinase C activation. Am. J. Physiol. 1994; 266: H1145-52.
9. Yamazaki T, Akiyama T, Kitagawa H, Takauchi Y, Kawada T, Sunagawa K. A new, concise dialysis approach to assessment of cardiac sympathetic nerve terminal abnormalities. Am. J. Physiol. 1997; 272: H1182-7.
10. Fishbein MC, Meerbaum S, Rit J et al. Early phase acute myocardial infarct size quantification: Validation of the triphenyl tetrazolium chloride tisue enzyme staining technique. Am. Heart J. 1981; 101: 593-600.
11. Mahiko G, Liu Y, Yang XM, Ardell JL, Cohen MV, Downey JM. Role of bradykinin in protection of ischemic preconditioning in rabbit hearts. Circ. Res. 1995; 77: 611-21.
12. 1B-adrenoceptors, pertusis toxin-sensitive G proteins, and protein kinase C. Circulation 1995; 92: 2259-65.
13. Thornton JD, Liu GS, Olsson RA, Downey JM. Intravenous pre-treatment with A1-selective adenosine analogues protects the heart against infarction. Circulation 1992; 85: 659-65.
14. Wang GY, Wu S, Pei JM, Yu XC, Wong TM. Kappa- but not delta-opioid receptors mediate effects of ischemic preconditioning on both infarct and arrythmia in rats. Am. J. Physiol. Heart Circ. Physiol. 2001; 280: H384-91.
15. Peart JN, Patel HH, Gross GJ. Delta-opioid receptor activation mimics ischemic preconditioning in the canine heart. J. Cardiovasc. Pharmacol. 2003; 42: 78-81.
16. Nakano A, Miura T, Ura N, Suzuki K, Shimamoto K. Role of angiotensin II type 1 receptor in preconditioning against infarction. Coron. Artery Dis. 1997; 8: 343-50.
17. 1-adrenoceptor activity regulates release of adenosine from the ischemic myocardium in dogs. Circ. Res. 1987; 60: 631-9.
18. 1-adrenoceptor activation increases ecto-5′-nucleotidase activity and adenosine release in rat cardiomyocytes by activating protein kinase C. Circulation 1995; 91: 2226-34.
19. Goncalves J, Queiroz G. Facilitatory and inhibitory modulation by endogenous adenosine of noradrenaline release in the epididymal portion of rat vas deferens. Naunyn Schmiedebergs Arch. Pharmacol. 1993; 348: 367-71.
20. 1- adrenergic agonists precondition rabbit ischemic myocardium independent of adenosine by direct activation of protein kinase C. Circ. Res. 1994; 75: 576-85.